Live Breaking News & Updates on Robert Keith Warner

Stay updated with breaking news from Robert keith warner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

RxSight (NASDAQ:RXST) Price Target Increased to $61.00 by Analysts at Oppenheimer

RxSight (NASDAQ:RXST – Get Free Report) had its target price raised by Oppenheimer from $54.00 to $61.00 in a research report issued on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price objective points to a potential upside of 8.73% from the company’s previous close. Several other equities analysts […] ....

United States , Stifel Nicolaus , Robert Keith Warner , Eric Weinberg , Advisors Inc , Bluepath Capital Management , Securities Exchange Commission , Steward Partners Investment Advisory , Morgan Stanley , Riverpark Advisors , Needham Company , Wells Fargo Company , Rxsight Inc , Get Free Report , Wells Fargo , Director Robert Keith Warner , Exchange Commission , Park Advisors , Partners Investment Advisory , Path Capital Management , Rxsight Daily , Nasdaq Rxst , Boost Price Target , Oppenheimer Holdings Inc ,

Robert Keith Warner Sells 14,502 Shares of RxSight, Inc. (NASDAQ:RXST) Stock

RxSight, Inc. (NASDAQ:RXST – Get Free Report) Director Robert Keith Warner sold 14,502 shares of RxSight stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $35.01, for a total transaction of $507,715.02. Following the sale, the director now owns 29,248 shares of the company’s stock, valued at […] ....

United States , Robert Keith Warner , Stifel Nicolaus , Bluepath Capital Management , Wells Fargo Company , Needham Company , Morgan Stanley , Ameritas Investment Partners Inc , Advisors Inc , Cubist Systematic Strategies , Rxsight Inc , Get Free Report , Director Robert Keith Warner , Keith Warner , Investment Partners , Path Capital Management , Rxsight Daily , Nasdaq Rxst , Insider Trading , Nsider Trades ,

Insider Selling: RxSight, Inc. (NASDAQ:RXST) Director Sells $507,715.02 in Stock

RxSight, Inc. (NASDAQ:RXST – Get Free Report) Director Robert Keith Warner sold 14,502 shares of the company’s stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $35.01, for a total value of $507,715.02. Following the completion of the sale, the director now owns 29,248 shares […] ....

United States , Stifel Nicolaus , Robert Keith Warner , Rxsight Inc , Vanguard Group Inc , Century Growth Investors , Needham Company , Wells Fargo Company , Lord Abbett , Artisan Partners Limited Partnership , Blackrock Inc , Morgan Stanley , Get Free Report , Director Robert Keith Warner , Keith Warner , Partners Limited Partnership , Vanguard Group , Rxsight Daily , Nasdaq Rxst , Insider Trading , Nsider Trades ,